Activation of rat alveolar macrophage-derived latent transforming growth factor beta-1 by plasmin requires interaction with thrombospondin-1 and its cell surface receptor, CD36.

[1]  R. Silverstein,et al.  Sense and Antisense cDNA Transfection of CD 36 ( Glycoprotein IV ) in Melanoma Cells , 2001 .

[2]  N. Kaminski,et al.  The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. , 1999, Cell.

[3]  N. Kaminski,et al.  The Integrin avb6 Binds and Activates Latent TGFb1: A Mechanism for Regulating Pulmonary Inflammation and Fibrosis , 1999 .

[4]  J. Munger.  The integrin αvβ6 binds and activates latent TGFβ1 : A mechanism for regulating pulmonary inflammation and fibrosis , 1999 .

[5]  J. Dignam,et al.  Role of carbohydrate structures in the binding of beta1-latency-associated peptide to ligands. , 1997, Biochemistry.

[6]  L. Daviet,et al.  Vascular Biology of CD36: Roles of this New Adhesion Molecule Family in Different Disease States , 1997, Thrombosis and Haemostasis.

[7]  D. Rifkin,et al.  TGF‐β Latency: Biological Significance and Mechanisms of Activation , 1997 .

[8]  N. Khalil,et al.  Plasmin regulates the activation of cell-associated latent TGF-beta 1 secreted by rat alveolar macrophages after in vivo bleomycin injury. , 1996, American journal of respiratory cell and molecular biology.

[9]  R. Silverstein,et al.  Regulation of monocyte CD36 and thrombospondin-1 expression by soluble mediators. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[10]  C. Legrand,et al.  Proteolysis of thrombospondin during cathepsin‐G‐induced platelet aggregation: functional role of the 165‐kDa carboxy‐terminal fragment , 1996, FEBS letters.

[11]  G. Tuszynski,et al.  The role of thrombospondin-1 in tumor progression and angiogenesis. , 1996, BioEssays : news and reviews in molecular, cellular and developmental biology.

[12]  J. Dignam,et al.  Structural characterization of the latent complex between transforming growth factor beta 1 and beta 1-latency-associated peptide. , 1996, The Biochemical journal.

[13]  J. Dignam,et al.  Structural characterization of the latent complex between transforming growth factor β 1 and β 1-latency-associated peptide , 1996 .

[14]  E. Chambaz,et al.  Thrombospondins selectively activate one of the two latent forms of transforming growth factor-beta present in adrenocortical cell-conditioned medium. , 1995, Endocrinology.

[15]  K. Driscoll,et al.  Alveolar macrophage cytokine and growth factor production in a rat model of crocidolite-induced pulmonary inflammation and fibrosis. , 1995, Journal of toxicology and environmental health.

[16]  M. Granick,et al.  Thrombospondin and transforming growth factor‐beta 1 increase expression of urokinase‐type plasminogen activator and plasminogen activator inhibitor‐1 in human MDA‐MB‐231 breast cancer cells , 1995, Cancer.

[17]  R. Silverstein,et al.  CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis , 1995, The Journal of experimental medicine.

[18]  H. Krutzsch,et al.  Regulation of Transforming Growth Factor-β Activation by Discrete Sequences of Thrombospondin 1 (*) , 1995, The Journal of Biological Chemistry.

[19]  Wim Timens,et al.  Leucocyte typing V. White cell differentiation antigens , 1995 .

[20]  S. Wahl,et al.  Transforming growth factor beta: the good, the bad, and the ugly , 1994, The Journal of experimental medicine.

[21]  S. Schultz-Cherry,et al.  The type 1 repeats of thrombospondin 1 activate latent transforming growth factor-beta. , 1994, The Journal of biological chemistry.

[22]  S. Mai,et al.  Overexpression of c-myc precedes amplification of the gene encoding dihydrofolate reductase. , 1994, Gene.

[23]  M. Höök,et al.  Heparin-binding peptides from thrombospondins 1 and 2 contain focal adhesion-labilizing activity. , 1993, The Journal of biological chemistry.

[24]  E. Allan,et al.  Plasminogen‐dependent activation of latent transforming growth factor beta (TGFβ) by growing cultures of osteoblast‐like cells , 1993, Journal of cellular physiology.

[25]  D. Danielpour,et al.  Regulation of alveolar macrophage transforming growth factor-beta secretion by corticosteroids in bleomycin-induced pulmonary inflammation in the rat. , 1993, The Journal of clinical investigation.

[26]  S. Schultz-Cherry,et al.  Thrombospondin causes activation of latent transforming growth factor- beta secreted by endothelial cells by a novel mechanism [published erratum appears in J Cell Biol 1993 Sep;122(5):following 1143] , 1993, Journal of Cell Biology.

[27]  P. Hogg,et al.  Thrombospondin is a tight-binding competitive inhibitor of neutrophil elastase. , 1993, The Journal of biological chemistry.

[28]  T Vogel,et al.  Inhibition of fibronectin binding and fibronectin-mediated cell adhesion to collagen by a peptide from the second type I repeat of thrombospondin , 1993, The Journal of cell biology.

[29]  P. Delmas,et al.  Expression of thrombospondin (TSP1) and its receptors (CD36 and CD51) in normal, hyperplastic, and neoplastic human breast. , 1993, Cancer research.

[30]  S. L. Gonias,et al.  Characterization of the antiplasmin activity of human thrombospondin-1 in solution. , 1993, The Biochemical journal.

[31]  Stacey Schul tz-Cherry.  Thrombospondin Causes Activation of Latent Transforming Growth Factor-Secreted by Endothelial Cells by a Novel Mechanism , 2002 .

[32]  P. Bornstein,et al.  Thrombospondins: structure and regulation of expression , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[33]  K. Miyazono,et al.  Transforming growth factor-beta 1, -beta 2, and -beta 3 secreted by a human glioblastoma cell line. Identification of small and different forms of large latent complexes. , 1992, The Journal of biological chemistry.

[34]  L. Leung,et al.  CD36 peptides enhance or inhibit CD36-thrombospondin binding. A two-step process of ligand-receptor interaction. , 1992, The Journal of biological chemistry.

[35]  R. Silverstein,et al.  Sense and antisense cDNA transfection of CD36 (glycoprotein IV) in melanoma cells. Role of CD36 as a thrombospondin receptor. , 1992, The Journal of biological chemistry.

[36]  S. Schultz-Cherry,et al.  Transforming growth factor-beta complexes with thrombospondin. , 1992, Molecular biology of the cell.

[37]  S. Keshav,et al.  The versatility of macrophages , 1992, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[38]  D. Rappolee,et al.  Macrophage-derived growth factors. , 1992, Current topics in microbiology and immunology.

[39]  D. Belin,et al.  Urokinase-catalyzed plasminogen activation at the monocyte/macrophage cell surface: a localized and regulated proteolytic system. , 1992, Current topics in microbiology and immunology.

[40]  A. Fontana,et al.  Protease inhibitors interfere with the transforming growth factor-beta-dependent but not the transforming growth factor-beta-independent pathway of tumor cell-mediated immunosuppression. , 1992, Journal of immunology.

[41]  J. Barnwell,et al.  Membrane glycoprotein IV (CD36) is physically associated with the Fyn, Lyn, and Yes protein-tyrosine kinases in human platelets. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[42]  K. Cutroneo,et al.  Bleomycin regulation of transforming growth factor-beta mRNA in rat lung fibroblasts and subpopulations. , 1991, Chest.

[43]  S. Phan,et al.  Stimulation of rat endothelial cell transforming growth factor-beta production by bleomycin. , 1991, The Journal of clinical investigation.

[44]  F. Maly,et al.  Human monocytes CD36 and CD16 are signaling molecules. Evidence from studies using antibody-induced chemiluminescence as a tool to probe signal transduction. , 1990, Immunology.

[45]  M. Sporn,et al.  Macrophage production of transforming growth factor beta and fibroblast collagen synthesis in chronic pulmonary inflammation , 1989, The Journal of experimental medicine.

[46]  A. Brody,et al.  Alpha-macroglobulin secreted by alveolar macrophages serves as a binding protein for a macrophage-derived homologue of platelet-derived growth factor. , 1989, American journal of respiratory cell and molecular biology.

[47]  K. Yamaguchi,et al.  Purification and structural analysis of a latent form of transforming growth factor-beta from rat platelets. , 1989, Journal of biochemistry.

[48]  R. Silverstein,et al.  Glycoprotein IV mediates thrombospondin-dependent platelet-monocyte and platelet-U937 cell adhesion. , 1989, The Journal of clinical investigation.

[49]  M. Sporn,et al.  Immunodetection and quantitation of the two forms of transforming growth factor‐beta (TGF‐β1 and TGF‐β2) secreted by cells in culture , 1989 .

[50]  S. O. Kolset,et al.  Sulfur-containing macromolecules in cultured monocyte-like cells. , 1988, Acta histochemica.

[51]  R. Senior,et al.  12-o-Tetradecanoyl-phorbol-13-acetate-differentiated U937 cells express a macrophage-like profile of neutral proteinases. High levels of secreted collagenase and collagenase inhibitor accompany low levels of intracellular elastase and cathepsin G. , 1986, The Journal of clinical investigation.

[52]  L. Leung,et al.  Role of thrombospondin in platelet aggregation. , 1984, The Journal of clinical investigation.

[53]  G. Fisher,et al.  Characteristics of Bovine Alveolar Macrophage Elastase , 1984, Journal of leukocyte biology.

[54]  B. Wiman.  On the reaction of plasmin or plasmin-streptokinase complex with aprotinin or α2-antiplasmin , 1980 .